Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers (Q80594566)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15382173%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15382173%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15382173%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

4

Stanislas Pol

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15382173%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Maryline Mancini-Bourgine

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15382173%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Hélène Fontaine

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15382173%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Christian Bréchot

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15382173%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Marie-Louise Michel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15382173%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

language of work or name

English

0 references

publication date

1 October 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15382173%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15382173%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15382173%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15382173%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

874-882

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15382173%20AND%20SRC:MED&resulttype=core&format=json

Hepatitis B virus infection

1 January 2020

cites work

1 reference

7 January 2021

The treatment of chronic viral hepatitis

1 reference

7 January 2021

Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group

1 reference

7 January 2021

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

1 reference

7 January 2021

Resistance of HBV to adefovir dipivoxil: a case for combination antiviral therapy?

1 reference

7 January 2021

Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase

1 reference

7 January 2021

Hepatitis B virus immunopathogenesis

1 reference

7 January 2021

Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B.

1 reference

7 January 2021

Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections.

1 reference

7 January 2021

Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection

1 reference

7 January 2021

Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection

1 reference

7 January 2021

Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.

1 reference

7 January 2021

Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy.

1 reference

7 January 2021

A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus. The CY1899 T Cell Vaccine Study Group

1 reference

7 January 2021

Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens

1 reference

7 January 2021

Efficacy and limitations of a specific immunotherapy in chronic hepatitis B

1 reference

7 January 2021

1 reference

7 January 2021

DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state

1 reference

7 January 2021

Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein.

1 reference

7 January 2021

DNA prime/canarypox boost-based immunotherapy of chronic hepatitis B virus infection in a chimpanzee

1 reference

7 January 2021

Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device

1 reference

7 January 2021

Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine

1 reference

7 January 2021

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

1 reference

7 January 2021

DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans

1 reference

7 January 2021

DNA-based immunization against the envelope proteins of the hepatitis B virus

1 reference

7 January 2021

DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines

1 reference

7 January 2021

Multiepitopic HLA-A*0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization

1 reference

7 January 2021

Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin

1 reference

7 January 2021

Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen

1 reference

7 January 2021

A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals

1 reference

7 January 2021

Translation of immunological knowledge into better treatments of chronic hepatitis B.

1 reference

7 January 2021

Cytokine-dependent anti-viral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection

1 reference

7 January 2021

Placebo-controlled trial of vaccination with hepatitis B virus surface antigen in hepatitis B virus transgenic mice

1 reference

7 January 2021

Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection

1 reference

7 January 2021

Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy

1 reference

7 January 2021

Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms

1 reference

7 January 2021

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

1 reference

7 January 2021

Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B.

1 reference

7 January 2021

Virus-Specific CD8+ Lymphocytes Share the Same Effector-Memory Phenotype but Exhibit Functional Differences in Acute Hepatitis B and C

1 reference

7 January 2021

Strategies for designing and optimizing new generation vaccines

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20408

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15382173%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference